All secondaries cause osteolytic lesions except
**Core Concept**
Osteolytic lesions are areas of bone destruction caused by the metastasis of cancer cells, leading to bone resorption and potential fractures. The type of bone lesion depends on the primary cancer type and its interaction with bone cells. In this context, secondaries (metastatic cancers) can cause either osteolytic or osteoblastic lesions, depending on the dominant cell type and growth factors involved.
**Why the Correct Answer is Right**
The majority of secondaries, especially those originating from breast, lung, kidney, and thyroid cancers, are osteolytic in nature. This is because these cancers often produce factors that stimulate osteoclast activity, leading to bone resorption and osteolytic lesions. In contrast, prostate cancer secondaries are predominantly osteoblastic, as they secrete growth factors that stimulate osteoblast activity, resulting in bone formation and osteoblastic lesions.
**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because, while some secondaries may be mixed osteolytic-osteoblastic, most prostate cancer secondaries are osteoblastic, not osteolytic.
* **Option B:** This option is incorrect because breast cancer secondaries are typically osteolytic, not osteoblastic.
* **Option C:** This option is incorrect because lung cancer secondaries can be either osteolytic or osteoblastic, but the majority are osteolytic.
* **Option D:** This option is incorrect because kidney cancer secondaries are also typically osteolytic, not osteoblastic.
**Clinical Pearl / High-Yield Fact**
When evaluating a patient with bone metastases, it's essential to consider the primary cancer type and the type of bone lesion present. Osteolytic lesions are more common in breast, lung, kidney, and thyroid cancers, while osteoblastic lesions are more typical of prostate cancer.
**Correct Answer: D.**